Spectacle Lenses With Highly Aspherical Lenslets for Slowing Myopia: A Randomized, Double-Blind, Cross-Over Clinical Trial

被引:10
|
作者
Sankaridurg, Padmaja [1 ,2 ]
Weng, Rebecca [1 ]
Tran, Huy [1 ]
Spiegel, Daniel P. [3 ]
Drobe, Bjorn [3 ]
Thao Ha [4 ]
Tran, Yen H. [4 ]
Naduvilath, Thomas [1 ,2 ]
机构
[1] Brien Holden Vis Inst BHVI, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia
[3] Essilor R&D Ctr Singapore, Singapore, Singapore
[4] Haiyen Eye Care, Ho Chi Minh City, Vietnam
关键词
PROGRESSION;
D O I
10.1016/j.ajo.2022.10.021
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To evaluate myopia progression with highly aspherical lenslet (HAL) spectacles vs conventional single vision (SV) spectacles. DESIGN: Prospective, double-blind, single-center, randomized, cross-over trial. METHOD: A total of 119 Vietnamese children (7-13 years of age, spherical equivalent refractive error [SE] = 0.75 to -4.75D) were randomized to wear either HAL or SV, and after 6 months (stage 1) crossed over to the other lens for another 6 months (stage 2). At the end of stage 2, both groups wore HAL for a further 6 months. In the order that lenses were worn at each stage, group 1 was designated HSH (HAL-SV-HAL) and group 2 SHH (SVHAL-HAL). The main outcome measures were a comparison between HAL and SV for change ( Delta) in SE and axial length (AL) during each stage; and a comparison of Delta SE/AL with SV between HSH and SHH groups to determine whether myopia rebounded when switched from HAL to SV (HSH group). RESULTS: Myopia progressed more slowly with HAL than with SV during stages 1 and 2 (SE Delta stage 1: -0.21 vs -0.27D, P =.317, stage 2: -0.05 vs -0.32D, P <.001; AL Delta stage 1: 0.07 vs 0.14 mm, P =.004; stage 2: 0.04 vs 0.17 mm, P <.001). Delta SE/AL with SV was not different between the HSH and SHH groups ( Delta SE -0.33 +/- 0.27D vs -0.27 +/- 0.42D, P =.208; Delta AL 0.17 +/- 0.13mm vs 0.13 +/- 0.15 mm, P =.092). An average of 14 hours per day of lens wear was reported with both lenses. CONCLUSIONS: In this cross-over trial, intergroup and intragroup comparisons indicate that HAL slows myopia. Children were compliant with lens wear, and data were not suggestive of rebound when patients were switched from HAL to SV. (Am J Ophthalmol 2023;247: 18-
引用
收藏
页码:18 / 24
页数:7
相关论文
共 50 条
  • [1] Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses A Randomized Clinical Trial
    Bao, Jinhua
    Huang, Yingying
    Li, Xue
    Yang, Adeline
    Zhou, Fengchao
    Wu, Junqian
    Wang, Chu
    Li, Yuhao
    Lim, Ee Woon
    Spiegel, Daniel P.
    Drobe, Bjorn
    Chen, Hao
    [J]. JAMA OPHTHALMOLOGY, 2022, 140 (05) : 472 - 478
  • [2] Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial
    Bao, Jinhua
    Huang, Yingying
    Li, Xue
    Yang, Adeline
    Lim, Ee Woon
    Spiegel, Daniel
    Drobe, Bjorn
    Chen, Hao
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [3] Spectacle lenses with highly aspherical lenslets for myopia control: 4-year clinical trial results
    Drobe, Bjorn
    Xue, Li
    Huang, Yingying
    Lim, Ee
    Bao, Jinhua
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [4] Spectacle lenses with slightly aspherical lenslets for myopia control: clinical trial design and baseline data
    Chen, Junhong
    Zhuo, Ran
    Chen, Jiayan
    Yang, Adeline
    Lim, Ee Woon
    Bao, Jinhua
    Drobe, Bjorn
    Spiegel, Daniel P.
    Chen, Hao
    Hou, Lijie
    [J]. BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [5] Spectacle lenses with slightly aspherical lenslets for myopia control: clinical trial design and baseline data
    Junhong Chen
    Ran Zhuo
    Jiayan Chen
    Adeline Yang
    Ee Woon Lim
    Jinhua Bao
    Björn Drobe
    Daniel P. Spiegel
    Hao Chen
    Lijie Hou
    [J]. BMC Ophthalmology, 22
  • [6] Comparing the effects of highly aspherical lenslets versus defocus incorporated multiple segment spectacle lenses on myopia control
    Hui Guo
    Xianfang Li
    Xiaoxiao Zhang
    Haizhao Wang
    Jianhua Li
    [J]. Scientific Reports, 13
  • [7] The ergogenic activity of cider vinegar: A randomized cross-over, double-blind, clinical trial
    Chiu, Hui-Fang
    Chiang, Michael
    Liao, Hui-Ju
    Shen, You-Cheng
    Venkatakrishnan, Kamesh
    Cheng, I-Shiung
    Wang, Chin-Kun
    [J]. SPORTS MEDICINE AND HEALTH SCIENCE, 2020, 2 (01) : 38 - 43
  • [8] Comparing the effects of highly aspherical lenslets versus defocus incorporated multiple segment spectacle lenses on myopia control
    Guo, Hui
    Li, Xianfang
    Zhang, Xiaoxiao
    Wang, Haizhao
    Li, Jianhua
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial
    Brambilla, Michela
    Cotelli, Maria
    Manenti, Rosa
    Dagani, Jessica
    Sisti, Davide
    Rocchi, Marco
    Balestrieri, Matteo
    Pini, Stefano
    Raimondi, Sara
    Saviotti, Francesco Maria
    Scocco, Paolo
    de Girolamo, Giovanni
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (10) : 1619 - 1628
  • [10] GALLOPAMIL AND DILTIAZEM - A DOUBLE-BLIND, RANDOMIZED, CROSS-OVER TRIAL IN EFFORT ISCHEMIA
    MARRACCINI, P
    ORSINI, E
    BRUNELLI, C
    NASSI, G
    GHIGLIOTTI, G
    IANNETTI, M
    CAPONNETTO, S
    LABBATE, A
    [J]. EUROPEAN HEART JOURNAL, 1992, 13 (03) : 404 - 410